First Analysis
http://www.firstanalysis.com/index.asp?PID=16First Analysis is an investment organization specializing in private equity, venture capital, investment banking, and equity research. The sectors in the firm’s coverage universe include outsourced services, IT products and services, and chemistry-enabled businesses. First Analysis was founded in 1981.
View Older Stories View More Recent Stories
-
Emergex Signs Agreement with ATCC to Advance Studies of its Yellow Fever Booster Vaccine Candidate
-
Esperion Announces Two NEXLETOL® (bempedoic acid) Data Presentations at the American College of Cardiology’s 71st Annual Scientific Session & Expo
-
Esperion Announces Two NEXLETOL® (bempedoic acid) Data Presentations at the American College of Cardiology’s 71st Annual Scientific Session & Expo
-
Two Years Into the Pandemic, Media Use Has Increased 17% Among Tweens and Teens
-
3billion to reveal its diagnostic performance at ACMG annual meeting 2022
-
PureCycle Technologies (PCT) Appoints Steven F. Bouck and Allen Jacoby to its Board
-
PureCycle Adds Top Industry Leaders to Board of Directors
-
Bristol-Myers Squibb (BMY), Nektar (NKTR) Announce Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin (BEMPEG) in Combination with Opdivo Did Not Meet Primary Endpoint
-
Bristol Myers Squibb and Nektar Announce Update on Phase 3 PIVOT IO-001 Trial Evaluating Bempegaldesleukin (BEMPEG) in Combination with Opdivo (nivolumab) in Previously Untreated Unresectable or Metas
-
Castle Biosciences Reports Fourth Quarter and Full-Year 2021 Results
-
KnowBe4 Research: Half of Employees Use Unauthorized File Services to Complete Work
-
KnowBe4 Research: Half of Employees Use Unauthorized File Services to Complete Work
-
New MAVENCLAD® Data at ACTRIMS Forum 2022 Show Favorable Efficacy Outcomes Versus Other Oral DMTs and Lower Occurrence of Further Relapses or Disability Progression
-
Insellerate Receives Growth Investment Led by Argentum
-
World’s glaciers contain less ice than thought - report
-
RedHill Biopharma (RDHL) Oral Opaganib Reduces Mortality by 70% Given on Top of Remdesivir and Corticosteroids in Severe COVID-19
-
RedHill Biopharma's Oral Opaganib Reduces Mortality by 70% Given on Top of Remdesivir and Corticosteroids in Severe COVID-19
-
Castle Biosciences Collaborates with the National Cancer Institute to Link DecisionDx®-Melanoma Testing Data with SEER Registries’ Cutaneous Melanoma Cases
-
EDF updates its nuclear output estimate in France for 2022
-
Kargo Announces First of Its Kind Partnership with NewsGuard and Industry-Leading Results with Oracle Moat, Validating Supply Quality
-
BeiGene to Present New Clinical Data on Tislelizumab at ESMO IO Congress 2021
-
PhaseBio Pharmaceuticals Inc. (PHAS) Reports Publication of Interim Results from Pivotal REVERSE-IT Phase 3 Trial of Bentracimab
-
PhaseBio Announces Publication of Interim Results from Pivotal REVERSE-IT Phase 3 Trial of Bentracimab in NEJM Evidence
-
SaaS Ecommerce Provider Miva Announces Strategic Growth Investment from Equality Asset Management
-
Shockwave Medical (SWAV) Unveils First One-Year Results of Coronary Intravascular Lithotripsy
-
Shockwave Medical Unveils First One-Year Results of Coronary Intravascular Lithotripsy
-
Shockwave Medical Unveils First One-Year Results of Coronary Intravascular Lithotripsy
-
New data at ASH spotlight Novartis recently approved Scemblix®, next-generation CAR-T platform and expanding hematology portfolio
-
NANOBIOTIX Provides Third Quarter Operational and Financial Update
-
Lender Price Receives Strategic Investment Led by Argentum to Support Rapid Growth
-
Byondis ESMO Late-Breaking Presentation Confirms ADC [Vic-] Trastuzumab Duocarmazine (SYD985) Superior to Physician's Choice in Pre-treated Locally Advanced or Metastatic HER2-Positive Breast Cancer
-
New White Paper From Westfleet Advisors Finds that Despite Aggressive Disclosure Efforts, U.S. Courts Continue to Protect Confidentiality of Litigation Funding
-
70% Of U.S. Office Workers Are Embracing a Return to the Office, New Survey Shows
-
NexPhase Capital Announces Investment in Selerix Systems
-
Checkpoint Surgical Completes $16M Equity Financing to Fuel Growth and Launch New Products
-
WellSky® to Acquire Healthify to Enhance Social Services Care Coordination Across the Continuum
-
Kno2 raises $15 million to accelerate its disruption of healthcare's interoperability status quo
-
New Data from the Phase 3 HELP Study™ Open-Label Extension Evaluating Safety and Efficacy of TAKHZYRO® (lanadelumab) for Hereditary Angioedema Patients to be Presented at European Academy of Allerg
-
Waters Arc Premier System Delivers Increased Precision and Certainty in Chromatographic Results
-
Latest global data finds nearly 8 million deaths from smoking in 2019, and 90% of new smokers addicted by age 25
-
CanPAC: A new tool to conserve and protect the Canadian eastern Arctic
-
Massachusetts ranks healthiest state in US on Sharecare's Community Well-Being Index as Mississippi sits in last place
-
Pear Therapeutics Presents Results of Two Analyses Showing Decreases in Healthcare Resource Utilization and Associated Costs in Patients Using reSET-O® in Treating Opioid Use Disorder
-
moneycorp Americas Unveils Industry-First FX M.A.P. Report in Canada
-
Sustainable Capital Advisors Adds Climate and Carbon Finance Expert Victor A. Rojas as Senior Vice President
-
BioAge Signs Exclusive Agreement With Amgen To Develop and Commercialize Amgen’s Phase 1 APJ Agonist To Treat Diseases of Aging
-
SmartCommerce Raises $13M led by Argentum to Accelerate Growth, and Passes $1Billion/Year Carting Volume Milestone
-
Hilco Commercial Industrial Hires Michelle Moreno as Managing Director in Investment Banking Unit
-
Playing It Safe: Why This Top NJ College Performing Arts Program Leverages Hard Science to Welcome Back Students
-
Visage Raises $7M Series A Led by First Analysis to Streamline Candidate Sourcing for Large Enterprise Employers

